These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1428230)

  • 1. Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 pre-menopausal women.
    Gnant MF; Seifert M; Jakesz R; Adler A; Mittlboeck M; Sevelda P
    Int J Cancer; 1992 Nov; 52(5):707-12. PubMed ID: 1428230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status and short-term clinical outcome.
    Mangia A; De Lena M; Barletta A; Marzullo F; Attolico M; Stea B; Petroni S; Labriola A; Cellamare G; Digiesi G; Altieri R; Schittulli F; Paradiso A
    J Exp Clin Cancer Res; 1998 Sep; 17(3):317-23. PubMed ID: 9894769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy.
    Holli K; Isola J; Hakama M
    Br J Cancer; 1995 Jan; 71(1):124-7. PubMed ID: 7819026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age as a prognostic factor for breast and regional nodal recurrence following breast conserving surgery and irradiation in stage I and II breast cancer.
    Halverson KJ; Perez CA; Taylor ME; Myerson R; Philpott G; Simpson JR; Tucker G; Rush C
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1045-50. PubMed ID: 8262825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
    Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T
    Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.
    Pujol P; Daurès JP; Brouillet JP; Maudelonde T; Rochefort H; Grenier J
    Br J Cancer; 1999 Feb; 79(5-6):909-14. PubMed ID: 10070889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
    Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
    Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast conservative surgery and local recurrence.
    Rezai M; Kraemer S; Kimmig R; Kern P
    Breast; 2015 Nov; 24 Suppl 2():S100-7. PubMed ID: 26432359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in prognostic factors in primary breast cancer throughout the menstrual cycle.
    Kroman N; Thorpe SM; Wohlfahrt J; Andersen KW; Mouridsen HT
    Eur J Surg Oncol; 2000 Feb; 26(1):11-6. PubMed ID: 10718172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of breast cancer surgery within the menstrual cycle: influence on lymph-node involvement, receptor status, postoperative metastatic spread and local recurrence.
    Rageth JC; Wyss P; Unger C; Hochuli E
    Ann Oncol; 1991 Apr; 2(4):269-72. PubMed ID: 1868022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor.
    Cooper LS; Gillett CE; Patel NK; Barnes DM; Fentiman IS
    Cancer; 1999 Nov; 86(10):2053-8. PubMed ID: 10570431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal breast cancer patients.
    Takeda Y; Nonaka Y; Yanagie H; Yoshizaki I; Eriguchi M
    Biomed Pharmacother; 2001; 55 Suppl 1():133s-137s. PubMed ID: 11774860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
    Fodor J
    Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up.
    Kunkler IH; Kerr GR; Thomas JS; Jack WJ; Bartlett JM; Pedersen HC; Cameron DA; Dixon JM; Chetty U;
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):829-38. PubMed ID: 22197227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer.
    Badwe RA; Gregory WM; Chaudary MA; Richards MA; Bentley AE; Rubens RD; Fentiman IS
    Lancet; 1991 May; 337(8752):1261-4. PubMed ID: 1674070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone receptor measurements and survival in 1335 consecutive patients with primary invasive breast carcinoma.
    Raabe NK; Hagen S; Haug E; Fossaa SD
    Int J Oncol; 1998 May; 12(5):1091-6. PubMed ID: 9538134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of estrogen and progesterone receptors to the menstrual cycle and menopausal status at the time of breast surgery].
    Karbowski B; Jackisch C; Deppe B; Schneider HP
    Zentralbl Gynakol; 1999; 121(8):367-74. PubMed ID: 10486879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.